Study ID: IXR-205-21-189
Study Title
- Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Teva Identifier
- IXR-205-21-189
ClinicalTrials.gov Identifier
- NCT00062504
Study Status
- Terminated
Trial Condition(s)
- Glioblastoma Multiforme | Anaplastic Astrocytoma|Anaplastic Oligodendroglioma | Anaplastic Mixed Oligoastrocytoma
Interventions
- Drug: Talampanel
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 07/01/2003 - 04/01/2006
Phase
- Phase 2
Study Type
Interventional